Emerging chemotherapeutic strategies in the management of intraocular retinoblastoma.
Bhisitkul
R B
RB
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114, USA.
Mukai
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D004333:Drug Administration Routes; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D011379:Prognosis; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D012175:Retinoblastoma / Q000188:drug therapy* / Q000532:radiotherapy